PRME
Prime Medicine, Inc.
2.90$
-5.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | – | – | – | – | – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 12.7% | – | – | – | – | – | 70.4% | – | – | – | 4.9% | 222.5% | 4.1% | 745.5% | 78.7% | 116.9% | 167.2% | 3,591.0% | 223.9% | 216.8% | – | – | |
| – | – | – | -12.7% | – | – | – | – | – | 29.6% | – | – | – | -4.9% | -122.5% | -4.1% | 100.0% | 100.0% | 100.0% | -67.2% | -3,491.0% | 100.0% | -116.8% | 100.0% | -1,025.6% | |
| – | – | – | 62.4% | – | – | – | – | – | 557.8% | – | – | – | 161.4% | 6,391.5% | 114.0% | 19,301.4% | 1,562.3% | 2,789.7% | 3,710.8% | 3,591.0% | 4,141.9% | 3,984.2% | 2,894.0% | 3,589.5% | |
| – | – | – | 25.4% | – | – | – | – | – | 184.7% | – | – | – | 50.9% | 1,888.0% | 33.4% | 6,746.9% | 563.5% | 913.6% | 1,176.4% | 914.9% | 1,758.6% | 2,033.3% | 956.8% | 1,335.4% | |
| – | – | – | 75.1% | – | – | – | – | – | 742.5% | – | – | – | 264.8% | 8,057.0% | 147.4% | 26,048.3% | 2,125.7% | 3,703.3% | 4,720.0% | 914.9% | 5,900.5% | 5,800.7% | 3,850.9% | 3,799.3% | |
| – | – | – | -87.8% | – | – | – | – | – | -742.5% | – | – | – | -264.8% | -8,179.5% | -147.4% | -25,948.3% | -2,025.7% | -3,603.3% | -4,787.2% | -4,406.0% | -5,800.5% | -5,917.5% | -3,750.9% | -4,824.9% | |
| – | – | – | – | – | – | – | – | – | 31.1% | – | – | – | 1.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | 19.0% | – | – | – | – | – | -757.6% | – | – | – | -255.5% | -7,720.3% | -146.8% | -25,128.2% | -1,936.6% | -3,568.8% | -4,716.7% | -4,129.1% | -5,498.7% | -5,738.6% | -3,649.0% | -4,613.1% | |
| – | – | – | 12.2% | – | – | – | – | – | -3.6% | – | – | – | 2.2% | 22.7% | -0.4% | – | – | – | – | – | – | – | – | – | |
| – | – | – | 6.7% | – | – | – | – | – | -754.0% | – | – | – | -255.5% | -7,743.0% | -146.5% | -25,128.2% | -1,936.6% | -3,568.8% | -4,716.7% | -4,129.1% | -5,498.7% | -5,738.6% | -3,649.0% | -4,613.1% | |
| – | – | – | 31.7% | – | – | – | – | – | -740.9% | – | – | – | -207.4% | -7,497.8% | -142.8% | -24,382.8% | -1,857.9% | -3,451.9% | -4,549.5% | -3,975.6% | -5,274.8% | -5,521.7% | -3,494.3% | -4,431.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.